CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Avectas has created Solupore, a cell engineering technology that enhances the delivery of therapeutic cargo to immune cells for cancer treatment. This innovation aims to reduce manufacturing costs and improve the accessibility of cell immunotherapy, potentially transforming cancer care.
There is encouraging news for cancer patients, a new treatment, cell immunotherapy, has been delivering spectacularclinical results and is a game changer because it is an entirely new way of treating cancer.
Cancer immunotherapy, in whicha patient’s own immune cells are ‘armed’ by cell engineering to target and kill cancer cells, gives levels of complete responsein patients.
The first cell immunotherapy drug was approved in August 2017 at a price of $475,000 per treatment.
To bringthese life-cha…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
